NCT00380250View on ClinicalTrials.gov

Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

590

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

July 31, 2006

Conditions
Irritable Bowel Syndrome With Constipation
Interventions
DRUG

Lubiprostone

DRUG

Placebo

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Sucampo Pharma Americas, LLC

INDUSTRY